<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>40(3)</volume><submitter>Adler L</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Evaluating the prevalence of long-COVID symptoms in patients with a history of mild or asymptomatic infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the factors associated with developing long-COVID.&lt;h4>Design&lt;/h4>A nationwide cohort study. Using a centralized database, we have identified patients with and without a history of SARS-CoV-2 infection 1-6 months before data collection. Patients were asked to fill out an online questionnaire through text messages.&lt;h4>Setting&lt;/h4>Israeli general practice.&lt;h4>Subjects&lt;/h4>2755 persons participated in the study in September 2021 (a response rate of 7.5%): 819 with and, 936 without a history of SARS-CoV-2 infection.&lt;h4>Main outcome measures&lt;/h4>We asked patients to provide details about their demogra</pubmed_abstract><journal>Scandinavian journal of primary health care</journal><pagination>342-349</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9848375</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.</pubmed_title><pmcid>PMC9848375</pmcid><pubmed_authors>Mizrahi Reuveni M</pubmed_authors><pubmed_authors>Patalon T</pubmed_authors><pubmed_authors>Gazit S</pubmed_authors><pubmed_authors>Azuri J</pubmed_authors><pubmed_authors>Adler L</pubmed_authors><pubmed_authors>Pinto Y</pubmed_authors><pubmed_authors>Perez G</pubmed_authors><pubmed_authors>Hoffman R</pubmed_authors><pubmed_authors>Yehoshua I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.</name><description>&lt;h4>Objective&lt;/h4>Evaluating the prevalence of long-COVID symptoms in patients with a history of mild or asymptomatic infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the factors associated with developing long-COVID.&lt;h4>Design&lt;/h4>A nationwide cohort study. Using a centralized database, we have identified patients with and without a history of SARS-CoV-2 infection 1-6 months before data collection. Patients were asked to fill out an online questionnaire through text messages.&lt;h4>Setting&lt;/h4>Israeli general practice.&lt;h4>Subjects&lt;/h4>2755 persons participated in the study in September 2021 (a response rate of 7.5%): 819 with and, 936 without a history of SARS-CoV-2 infection.&lt;h4>Main outcome measures&lt;/h4>We asked patients to provide details about their demogra</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T13:53:12.132Z</modification><creation>2025-04-04T13:53:12.132Z</creation></dates><accession>S-EPMC9848375</accession><cross_references><pubmed>36314555</pubmed><doi>10.1080/02813432.2022.2139480</doi></cross_references></HashMap>